Accelerating pooled licensing of medicines to enhance global production and equitable access

8 July 2022 - From October to November, 2021, the pharmaceutical firms Merck and Pfizer licensed their new COVID-19 oral antiviral ...

Read more →

Patient reported outcome assessment must be inclusive and equitable

5 May 2022 - Patient reported outcomes are increasingly collected in clinical trials and in routine clinical practice, but strategies ...

Read more →

Vaccine approval before Phase 3 trial results: a consequence of vaccine access inequity

2 March 2022 - The final Phase 3 clinical data for CanSino Biologics' adenovirus type 5 vector vaccine show that Ad5-nCoV ...

Read more →

Booster shots ‘make a mockery of vaccine equity,’ the WHO’s Africa director says

19 August 2021 - The Africa director at the World Health Organization, Dr. Matshidiso Moeti, criticized the decisions by some ...

Read more →

COVID-19 vaccines: time to talk about the uncertainties

20 October 2020 - Plan now for decisions on which vaccines should go to whom, when and how often. ...

Read more →

Remdesivir: US purchase of world stocks sparks new “hunger games,” warn observers

 3 July 2020 - The US has bought up almost all the world’s supply of the antiviral drug remdesivir in ...

Read more →

The equitable distribution of COVID-19 therapeutics and vaccines

7 May 2020 - Scientists from across the globe are racing to develop effective vaccines and therapeutics for COVID-19.  ...

Read more →

The $2.1 million question: what are the medical, ethical implications of the world's priciest drug?

10 June 2019 - With last month’s FDA approval, Zolgensma became the world’s most expensive medication.  ...

Read more →

Mission possible: moving the needle forward to advance health equity

26 April 2018 - Every April our country observes National Minority Health Month to spotlight what we’re doing to eliminate health ...

Read more →

Accelerated drug approval and health inequality

5 July 2016 - This Viewpoint argues that the acceleration of the drug approval process could unequally distribute the costs and ...

Read more →

Accelerated drug approval and health inequality

13 June 2016 - This viewpoint argues that the acceleration of the drug approval process could unequally distribute the costs and ...

Read more →